alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[639 NYS2d 763]

#### In the Matter of Vincent Agnello, an Attorney, Respondent. Grievance Committee of the Eighth Judicial District, Petitioner.

Fourth Department,

March 8, 1996

APPEARANCES OF COUNSEL

*Gerard M. LaRusso,*Buffalo *(Roderick Quebral*of counsel), for petitioner.

*John T. Frizzell,*Buffalo, for respondent.

OPINION OF THE COURT

Per Curiam.

Respondent was admitted to the practice of law by this Court on June 26, 1980 and maintains an office in Niagara Falls. The Grievance Committee filed a petition charging respondent with two counts of professional misconduct arising from his false *194representations to a client concerning a settlement agreement and his neglect of legal matters. Respondent, in his answer, admits the allegations in the petition.

We conclude that respondent violated the following Disciplinary Rules of the Code of Professional Responsibility, effective September 1, 1990:

DR 1-102 (A) (4) (22 NYCRR 1200.3 [a] [4]) — engaging in conduct involving dishonesty, fraud, deceit or misrepresentation;

DR 1-102 (A) (8) (22 NYCRR 1200.3 [a] [8]) — engaging in conduct that adversely reflects on his fitness to practice law;

DR 6-101 (A) (3) (22 NYCRR 1200.30 [a] [3]) — neglecting a legal matter entrusted to him; and

DR 7-101 (A) (2) (22 NYCRR 1200.32 [a] [2]) — failing to carry out a contract of employment entered into with a client for professional services.

We have considered the matters in mitigation presented by respondent, including his previously unblemished record, his service to the community and the remorse that respondent has expressed for his misconduct. We conclude that respondent should be censured (see, *Matter of Foley,*211 AD2d 97; *Matter of Greenman,*201 AD2d 63; *Matter of Foley,*194 AD2d 111).

Pine, J. P., Lawton, Balio, Davis and Boehm, JJ., concur.

Order of censure entered.
#### Sivyer Steel Casting Company and another, Appellants, vs. Industrial Commission and others, Respondents.

*November 4, 1935*

February *4, 1936.*

*253For the appellants there was a brief by *Otjen & Otjen*of Milwaukee, and oral argument by *C. J. Otjen.*

For the respondent Industrial Commission there was a brief by the *Attorney General*and *Mortimer Levitan,*assistant attorney general, and oral argument by *Mr. Levitan.*

For the respondent Dziedzic there was a brief by *Joseph A. Padway,*attorney, and *L. A. Tarrell*of counsel, both of Milwaukee, and oral argument by *Mr. Tarrell.*

*254For the respondent Employers Mutual Liability Insurance Company there was a brief by *Quarles, Spence' & Quarles,*attorneys, and *Kenneth Grubb*and *Jefferson D. Burrus*of counsel, all of Milwaukee, and oral argument by *Mr. Grubb.*

The following opinion was filed December 3, 1935 :

Fairchild, J.

The employee was exposed to silica dust, but he suffered no disability such as described in the Workmen’s Compensation Act as it stood at the time of his discharge. This brings the case within the rule of *North End Foundry Co. v. Industrial Comm.*217 Wis. 363, 258 N. W. 439, and *Motor Castings Co. v. Industrial Comm.*219 Wis. 204, 262 N. W. 577. There being no wage loss or com-pensable disability due to an occupational disease, the award may not stand.

*By the Court.*— Judgment reversed, and cause remanded with directions to enter judgment setting aside the award.

A motion for a rehearing was denied, without hosts, on February 4, 1936:
```

[Federal Register Volume 89, Number 224 (Wednesday, November 20, 2024)]
[Notices]
[Page 91771]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-27099]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration

Notice of Supplemental Funding; National Rural Health Information 
Clearinghouse Program

AGENCY: Health Resources and Services Administration (HRSA), Department 
of Health and Human Services.

ACTION: Notice of supplemental funding.

-----------------------------------------------------------------------

SUMMARY: HRSA provided supplemental funds to the National Rural Health 
Information Clearinghouse Program recipient, University of North 
Dakota, to develop toolkits and other resources that address strategies 
to promote rural community health and support the improvement of health 
care in rural areas.

FOR FURTHER INFORMATION CONTACT: Sarah Scott, Federal Office of Rural 
Health Policy, HRSA, at [email protected] and 301-287-2619.

SUPPLEMENTARY INFORMATION: 
    Intended Recipient of the Award: University of North Dakota.
    Amount of Non-Competitive Award: One award for $782,000.
    Project Period: June 1, 2020, through May 31, 2025.
    Assistance Listing (CFDA) Number: 93.223.
    Award Instrument: Cooperative Agreement Supplement for Services.
    Authority: Section 711 of the Social Security Act (42 U.S.C. 912).

                                      Table 1--Recipients and Award Amounts
----------------------------------------------------------------------------------------------------------------
              Grant number                   Award recipient name             City, State          Award amount
----------------------------------------------------------------------------------------------------------------
U56RH05539..............................  University of North Dakota  Grand Forks, ND...........        $782,000
----------------------------------------------------------------------------------------------------------------

    Justification: This supplement allows the University of North 
Dakota to build on past and ongoing projects to improve health care in 
rural areas by advancing the knowledge base regarding strategies to 
support and enhance rural community health. The University of North 
Dakota has longstanding experience developing resources like toolkits 
and webinars to support a broad range of rural health topics. The 
supplement will allow the University of North Dakota to create new 
toolkits and resources on important topics related to rural community 
health and health care.

Diana Espinosa,
Principal Deputy Administrator.
[FR Doc. 2024-27099 Filed 11-19-24; 8:45 am]
BILLING CODE 4165-15-P
```
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.J. Res. 99 Enrolled Bill (ENR)]

        H.J.Res.99

                     One Hundred Fifteenth Congress

                                 of the

                        United States of America

                          AT THE FIRST SESSION

          Begun and held at the City of Washington on Tuesday,
          the third day of January, two thousand and seventeen

                            Joint Resolution

 
 Making further continuing appropriations for fiscal year 2017, and for 
                             other purposes.

    Resolved by the Senate and House of Representatives of the United 
States of America in Congress assembled, That the Continuing 
Appropriations Act, 2017 (division C of Public Law 114-223) is further 
amended by--
        (1) striking the date specified in section 106(3) and inserting 
    ``May 5, 2017''; and
        (2) inserting after section 201 the following new section:
    ``Sec. 202. (a) This section may be cited as the `Further Continued 
Health Benefits for Miners Act'.
    ``(b) Section 402(h)(2)(C)(ii) of the Surface Mining Control and 
Reclamation Act of 1977 (30 U.S.C. 1232(h)(2)(C)(ii)) is amended--
        ``(1) in subclause (II), by striking `April 30, 2017' and 
    inserting `May 5, 2017';
        ``(2) in subclause (II)(aa), by striking `the Continued Health 
    Benefits for Miners Act' and inserting `the Further Continued 
    Health Benefits for Miners Act'; and
        ``(3) by adding at the end the following: `For purposes of 
    subclause (II)(aa), a beneficiary enrolled in the Plan as of the 
    date of the enactment of the Further Continued Health Benefits for 
    Miners Act shall be deemed to have been eligible to receive health 
    benefits under the Plan on January 1, 2017.'.
    ``(c) The provisions of section 167(d) of Public Law 114-223 (as 
added by Public Law 114-254) shall apply to this section.''.

                               Speaker of the House of Representatives.

                            Vice President of the United States and    
                                               President of the Senate.
```
<TABLE> <S> <C>

<PAGE>
<ARTICLE> 5
<CIK> 0000927362
<NAME> PRI AUTOMATION, INC.
<RESTATED>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                             OCT-01-1997
<PERIOD-END>                               DEC-28-1997
<CASH>                                          38,908
<SECURITIES>                                     3,078
<RECEIVABLES>                                   58,833
<ALLOWANCES>                                   (1,300)
<INVENTORY>                                     31,859
<CURRENT-ASSETS>                               156,408
<PP&E>                                          23,128
<DEPRECIATION>                                 (9,462)      
<TOTAL-ASSETS>                                 172,818
<CURRENT-LIABILITIES>                           41,887
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           196
<OTHER-SE>                                     130,581
<TOTAL-LIABILITY-AND-EQUITY>                   172,818
<SALES>                                         65,133
<TOTAL-REVENUES>                                65,133
<CGS>                                           36,076
<TOTAL-COSTS>                                   36,076
<OTHER-EXPENSES>                                27,035<F1>
<LOSS-PROVISION>                                   700
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  2,171
<INCOME-TAX>                                     2,578
<INCOME-CONTINUING>                              (407)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     (407)
<EPS-PRIMARY>                                   (0.02)
<EPS-DILUTED>                                   (0.02)
<FN>
<F1>Includes $8,417 in-process R&D.
</FN>
        

</TABLE>
Exhibit 24.10**POWER OF ATTORNEY**KNOW ALL MEN BY THESE PRESENTS     WHEREAS, ALCAN INC., a Canadian corporation (the “Company”), proposes shortly to file with theSecurities and Exchange Commission, under the provisions of the Securities Act of 1934 as amended(the “Act”), the Annual Report on Form 10-K pursuant to Section 13 or 15 (d) of the Act.     WHEREAS, the undersigned is an Officer and/or a Director of the Company as indicated below;     NOW, THEREFORE, the undersigned hereby constitutes and appoints R. Millington, D. McAuslandand P. Chenard and each of them, as attorneys for the undersigned and in the undersigned’s name,place and stead, and in each of the undersigned’s offices and capacities as an Officer and/or aDirector of the Company, to execute and file such Annual Report on Form 10-K, hereby giving andgranting to said attorneys full power and authority to do and perform all and every act and thingwhatsoever requisite and necessary to be done in and about the premises as fully, to all intentsand purposes, as the undersigned might or could do if personally present at the doing thereof,hereby ratifying and confirming all that said attorneys may or shall lawfully do, or cause to bedone, by virtue hereof.     IN WITNESS WHEREOF, I have hereunto set my hand this 27th day of February 2007.         Signed: /s/ Paul M. Tellier   Name:  Paul M. Tellier   Title:  Director
<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          28,550
<SECURITIES>                                    83,207
<RECEIVABLES>                                   41,606
<ALLOWANCES>                                   (2,197)
<INVENTORY>                                          0
<CURRENT-ASSETS>                               155,755
<PP&E>                                         125,338
<DEPRECIATION>                                (66,187)
<TOTAL-ASSETS>                                 216,573
<CURRENT-LIABILITIES>                           36,757
<BONDS>                                          9,357
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                           319
<OTHER-SE>                                     111,925
<TOTAL-LIABILITY-AND-EQUITY>                   216,573
<SALES>                                              0
<TOTAL-REVENUES>                               112,379
<CGS>                                                0
<TOTAL-COSTS>                                   80,136
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               1,015
<INCOME-PRETAX>                                 36,781
<INCOME-TAX>                                    15,305
<INCOME-CONTINUING>                             21,476
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    21,476
<EPS-BASIC>                                     0.67
<EPS-DILUTED>                                     0.63


</TABLE>
No. 90-488.

#### Arvin *v.*United States.

C. A. 9th Cir. Cer-tiorari denied.
No. 75-1917.

#### In re Robb.

Appeal from Sup. Ct. N. H. dismissed for want of substantial federal question.
|   | 1. | The      Annual Report on Form 10-K of the Company for the year ended December 31,      2007 (the “Report”) fully complies with the requirements of Section 13(a)      or 15(d) of the Securities Exchange Act of 1934;  and |
|--------|----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|   | 2. | The      information contained in the Report fairly represents, in all material      respects, the financial condition and results of operations of the      Company. |
|--------|----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| Date:        March      28, 2008     | by:           /s/      Roger S. Marcus     |
|--------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------|
|                                                                                             | Roger S. Marcus, Chairman of the      Board, Chief Executive Officer and  Director                               |

|   | by:           /s/      Howard N. Feist III     |
|--------|----------------------------------------------------------------------------------------------------------------------|
|   | Howard N. Feist III, Vice      President Finance and Chief Financial  Officer                                        |
_______________________________________ __ Michigan Supreme Court 

# Order

Lansing, Michigan

May 27, 2008 Clifford W. Taylor, Chief Justice
136075 Michael F. Cavanagh Elizabeth A. Weaver Marilyn Kelly Maura D. Corrigan PEOPLE OF THE STATE OF MICHIGAN, Plaintiff-Appellee, Robert P. Young, Jr. Stephen J. Markman, Justices

v SC: 136075 COA: 275753 Wayne CC: 05-008334-01 TERRELL THOMAS KENNEDY, Defendant-Appellant.

________________ _______________ __________/

On order of the Court, the application for leave to appeal the January 29, 2008 judgment of the Court of Appeals is consid ered, and it is DENIED, because we are not persuaded that the questions presented should be reviewed by this Court.

t0519 I, Corbin R. Davis, Clerk of the Mi chigan Supreme Cour t, certify that the foregoing is a true and complete copy of the order entered at the direction of the Court.

May 27, 2008

Clerk
IB 

Union Calendar No. 41 

115TH CONGRESS 

1ST SESSION H. R. 1219 

[Report No. 115–70] 

To amend the Investment Company Act of 1940 to expand the investor 

limitation for qualifying venture capital funds under an exemption from 

the definition of an investment company. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 27, 2017 

Mr. MCHENRY (for himself and Ms. VELA ́ZQUEZ) introduced the following bill; 

which was referred to the Committee on Financial Services 

MARCH 29, 2017 

Additional sponsors: Mr. HOLLINGSWORTH, Mr. SHERMAN, and Mr. 

GOTTHEIMER

MARCH 29, 2017 

Committed to the Committee of the Whole House on the State of the Union 

and ordered to be printed 


sradovich on DSK3GMQ082PROD with BILLS
2 

•HR 1219 RH

A BILL 

To amend the Investment Company Act of 1940 to expand 

the investor limitation for qualifying venture capital 

funds under an exemption from the definition of an 

investment company. 


sradovich on DSK3GMQ082PROD with BILLS
3 

•HR 1219 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Supporting America’s 

5 Innovators Act of 2017’’. 

6 SEC. 2. INVESTOR LIMITATION FOR QUALIFYING VENTURE 

7 CAPITAL FUNDS. 

8 Section 3(c)(1) of the Investment Company Act of 

9 1940 (15 U.S.C. 80a–3(c)(1)) is amended— 

10 (1) in the matter preceding subparagraph (A), 

11 by inserting ‘‘(or, in the case of a qualifying venture 

12 capital fund, 250 persons)’’ after ‘‘one hundred per13 sons’’; and 

14 (2) by adding at the end the following: 

15 ‘‘(C)(i) The term ‘qualifying venture cap16 ital fund’ means a venture capital fund that has 

17 not more than $10,000,000 in aggregate capital 

18 contributions and uncalled committed capital, 

19 with such dollar amount to be indexed for infla20 tion once every 5 years by the Commission, be21 ginning from a measurement made by the Com22 mission on a date selected by the Commission, 

23 rounded to the nearest $1,000,000. 

24 ‘‘(ii) The term ‘venture capital fund’ has 

25 the meaning given the term in section 


sradovich on DSK3GMQ082PROD with BILLS
4 

•HR 1219 RH

1 275.203(l)–1 of title 17, Code of Federal Regu2 lations, or any successor regulation.’’. 


sradovich on DSK3GMQ082PROD with BILLS

sradovich on DSK3GMQ082PROD with BILLS
Union Calendar No. 41 

115TH CONGRESS 

1ST SESSION H. R. 1219 

[Report No. 115–70] 

A BILL 

To amend the Investment Company Act of 1940 to 

definition of an investment company. ture capital funds under an exemption from the expand the investor limitation for qualifying venMARCH 29, 2017 

Committed to the Committee of the Whole House on the 

State of the Union and ordered to be printed 


sradovich on DSK3GMQ082PROD with BILLS
#### The People of the State of New York, Respondent, v Santiago Vega, Appellant.

[631 NYS2d 329]

Judgment, Supreme Court, New York County (Murray Mogel, J.), rendered May 20, 1993, convicting defendant, after a jury trial, of two counts of criminal sale of a controlled substance in the third degree, and sentencing him, as a second felony offender, to concurrent terms of 41/2 to 9 years, unanimously affirmed.

Defendant’s guilt was proven by legally sufficient evidence, and the verdict was not against the weight of the evidence. The identification of the surveilling police officer, who observed defendant from a rooftop vantage point for some 20 minutes twice exchange vials for money, was not unreliable simply because the officer lost sight of defendant after the second sale and did not radio his description until he reappeared 10 to 15 minutes later *(see, People v Betancourt,*168 AD2d 276, *lv denied 77*NY2d 875). The testimony of one eyewitness, if credited, is sufficient to establish guilt beyond a reasonable doubt *(see, People v Arroyo,*54 NY2d 567, 578, *cert denied*456 US 979), and credibility of such a witness is enhanced where, as here, he is "trained and experienced * * * [in] the detection of criminal activity and the apprehension and conviction of the perpetrator” *(People v Morales,*37 NY2d 262, 271). Further corroboration of the officer’s identification is found in his accurate description of the two buyers. On the record before us, we find no basis to disturb the jury’s determinations of credibility and identification *(see, People v Mosley,*112 AD2d 812, 813-814, *affd*67 NY2d 985). Concur — Sullivan, J. P., Rubin, Kupferman, Asch and Nardelli, JJ.
AMENDING AGREEMENT NO. 1


THIS AMENDING AGREEMENT made effective as of the 12 th day of March, 2015.


BETWEEN:


ONCOYLYTICS BIOTECH (U.S.), INC.,


("OBUS")


- and -


MARY ANN DILLAHUNTY


(the "Employee")


WHEREAS the Employee is an officer of OBUS whose terms of employment are set forth in the Executive Employment Agreement ("Employment Agreement") dated effective January 22, 2009;


AND WHEREAS OBUS and the Employee wish to amend the Employment Agreement;


NOW THEREFORE in consideration of the mutual covenants contained in this Amending Agreement, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, it is agreed as follows:


Section 1 – Amendments





The Employment Agreement is hereby amended by replacing Section 3(1) with the following:





“Commencing January 1, 2015, OBUS shall pay to the Employee a salary of ONE HUNDRED SIXTY-NINE THOUSAND THREE HUNDRED SEVENTY-ONE DOLLARS AND SEVENTY-THREE CENTS ($169,371.73) U.S. DOLLARS per annum, exclusive of bonuses, benefits and other compensation, payable in equal installments of FOURTEEN THOUSAND ONE HUNDRED FOURTEEN DOLLARS AND THIRY-ONE CENTS ($14,114.31) U.S. DOLLARS on the last day of each month.”











Section 2 – Effective Date





(1)    This Amending Agreement shall be effective from and after January 1, 2015.





(2)    In all other respects the parties confirm that the Employment Agreement, as amended, shall remain in full force and effect.


ONCOLYTICS BIOTECH (U.S.), INC.Per:/s/ Alan J. TuchmanAlan J. Tuchman, M.D.Chief Medical OfficerPer:/s/ Kirk LookKirk LookChief Financial Officer





/s/ Margaret Kowalczewski/s/ Mary Ann DillahuntyWITNESSMARY ANN DILLAHUNTY
EXHIBIT (32.1)


                        C.E.O. Certification pursuant to
                   Exchange Act Rules 13a-14(b) and 15d-14(b)


<PAGE>
                                                                    EXHIBIT 32.1


                        C.E.O. CERTIFICATION PURSUANT TO
                   EXCHANGE ACT RULES 13a-14(b) AND 15d-14(b)


     In connection with the Annual Report of American Consumers, Inc. (the
"Company") on Form 10-K for the period ending May 29, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), the
undersigned hereby certifies, pursuant to 18 U.S.C. Sec. 1350 (as adopted
pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002) that he is the Chief
Executive Officer of the Company and that:  (1) the Report fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of
1934, and (2) the information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company as of and for the periods covered in the Report.

/s/ Michael A. Richardson
___________________________________
Michael A. Richardson
Chairman and Chief Executive Officer
American Consumers, Inc.


Date:  August 26, 2004


<PAGE>